Page 180 - FINAL PROGRAM

Reproductive endocrinology
P-660 Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis
L. Xianhua (China)
P-661 The “normal” range of FMR1 triple CGG repeats may be associated with primary ovarian insuf ciency in China
C. Lu (China)
P-662 Comparison of results treated with double stimulation protocol and short down-regulation protocol for ovarian stimulation in poor ovarian responder: a prospective matched cohort study
Y. Li (China)
P-663 Hydrogen sul de is an endogenous modulator of vaginal lubrication
Q. Sun (China)
P-664 Low intensity laser therapy: possible strategy to restore fertility in premature ovarian failure induced by chemotherapy?
I. de Zuñiga (Argentina)
P-665 Cardiovascular risk pro le of women beyond 45 years of age previously diagnosed with premature ovarian insuf ciency compared to premenopausal women of comparable age N. Daan (The Netherlands)
P-666 Pharmacological inhibition of m-TORC1 prevents cyclophosphamide-induced over-activation of the primordial follicle pool through PI3K/AKT/m-TOR signaling pathway in mice
L. Zhou (China)
P-667 Unravelling the role of extra- and intra-ovarian androgen receptor-mediated mechanisms driving the development of ovarian polycystic ovary syndrome (PCOS) traits
K. Walters (Australia)
P-668 The controlled ovarian stimulation outcome is affected by Anti-Müllerian Hormone Receptor II genotypes
L. Lazaros (Greece)
P-669 Acetyl-L-Carnitine (ALC) and L-Carnitine (LC) effects on neuroendocrine control of reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea (FHA)
A. Genazzani (Italy)
P-670 The impact of thyroid autoimmunity on IVF/ICSI outcome: a systematic review and meta- analysis
A. Busnelli (Italy)
P-671 Majority of young females with occult premature ovarian insuf ciency menstruate regularly: why we should not rely on menstrual status as a marker of ovarian reserve
Y. Güzel (Turkey)
176